Delivery of nasal powders of β-cyclodextrin by insufflation

Pharmaceutical Research

Volumn 13, Issue 5, 1996, Pages 734-738

  De Ascentiis, Alessia ^a   Bettini, Ruggero ^a   Caponetti, Giovanni ^a   Catellani, Pier Luigi ^a   Peracchia, Maria Teresa ^a   Santi, Patrizia ^a   Colombo, Paolo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Insufflation; Nasal powder; Nasal powder delivery; Powder properties

Indexed keywords

BETA CYCLODEXTRIN; DRUG CARRIER; POVIDONE; PROGESTERONE;

AERATION; ARTICLE; BIOAVAILABILITY; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG GRANULATION; DRUG RELEASE; NOSE MUCOSA; PARTICLE SIZE; POWDER; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CYCLODEXTRINS; DRUG CARRIERS; INSUFFLATION; POWDERS; PROGESTERONE; RABBITS;

EID: 0029948167     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016099516757     Document Type: Article

References (15)

1. V. H. L. Lee. Penetration and enzymatic barriers to peptide and protein absorption. Adv. Drug Deliv. Rev. 4:171-207 (1990).
2. S. Gizurarson. The relevance of nasal physiology to the design of drug absorption studies. Adv. Drug Deliv. Rew. 11:329-347 (1993).
3. A. D. Chediak, A. Wanner. The circulation of the airways: anatomy, physiology and potential role in drug delivery to the respiratory tract. Adv. Drug Deliv. Rew. 5:11-18 (1990).
4. M. A. Sarkar. Drug metabolism in the nasal mucosa. Pharm. Res. 9:1-9 (1992).
5. M. A. H. Russell, M. J. Jarvis, C. Feyerabend. A new age for snuff?. Lancet 474-475 (1980).
6. S. P. Vyas, S. K. Goswami, R. Singh. Liposomes based nasal delivery system of nifedipine: development and characterization. Int. J. Pharm. 118:23-30 (1995).
7. L. Illum. Drug delivery systems for nasal application. S.T.P. Pharma 3:594-598 (1987).
8. J. C. Hardy, S. W. Lee, C. G. Wilson. Intranasal drug delivery by spray and drops. J. Pharm. Pharmacol. 3:294-297 (1985).
9. N. G. M. Schipper, S. G. Romeijn, J. C. Verhoef, F. W. H. M. Merkus. Nasal insulin delivery with dimethyl-β-cyclodextrin as an absorption enhancer in rabbits: powders more effective than liquid formulations. Pharm. Res. 5:682-686 (1993).
10. P. Edman, E. Bjork, L. Ryden. Microspheres as a nasal delivery system for peptide drugs. J. Conyr. Rel. 21:165-172 (1992).
11. T. Nagai, Y. Nishimoto, N. Nambu, Y. Suzuki, K. Sekine. Powder dosage form of insulin for nasal administration. J. Contr. Rel. 1:15-22 (1984).
12. J. M. Aiache. Les preparations pour inhalation. S.T.P. Pharma 6:753-761 (1990).
13. M. T. Vidgren, A. Karkkainen, P. Karjalainen, J. Nuutinen. Effect of powder inhaler design on drug deposition in respiratory tract. Int. J. Pharm. 42:221-216 (1988).
14. D. Provasi, A. De Ascentiis, P. Colombo. Powder delivery from a device for nasal application. 12th Pharmaceutical Techn. Conference (Elsinore) 3:98-111 (1993).
15. D. Provasi, A. De Ascentiis, A. Minutello, P. Colombo, P. L. Catellani. Nasal powders of Progesterone: manufacturing and bioavailability. Eur. J. Phar. Biopharm. 40:223-227 (1994).